Shengxi Chen

1.5k total citations
68 papers, 1.2k citations indexed

About

Shengxi Chen is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Shengxi Chen has authored 68 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 9 papers in Pathology and Forensic Medicine and 8 papers in Oncology. Recurrent topics in Shengxi Chen's work include RNA and protein synthesis mechanisms (21 papers), DNA and Nucleic Acid Chemistry (11 papers) and RNA modifications and cancer (10 papers). Shengxi Chen is often cited by papers focused on RNA and protein synthesis mechanisms (21 papers), DNA and Nucleic Acid Chemistry (11 papers) and RNA modifications and cancer (10 papers). Shengxi Chen collaborates with scholars based in United States, China and United Kingdom. Shengxi Chen's co-authors include Sidney M. Hecht, Larisa M. Dedkova, Haihe Jiang, Nour Eddine Fahmi, Stephen J. Benkovic, Rumit Maini, Sandipan Chowdhury, R. J. Paul, Lingjin Huang and Chandrabali Bhattacharya and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Shengxi Chen

66 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengxi Chen United States 22 802 231 126 108 92 68 1.2k
Devkumar Mustafi United States 20 343 0.4× 67 0.3× 44 0.3× 130 1.2× 72 0.8× 74 1.1k
L B Chen United States 7 728 0.9× 138 0.6× 32 0.3× 198 1.8× 48 0.5× 8 1.2k
J. Keith Wright Germany 22 1.2k 1.5× 67 0.3× 92 0.7× 182 1.7× 57 0.6× 49 1.7k
Gerda Szakonyi Hungary 16 213 0.3× 71 0.3× 42 0.3× 112 1.0× 28 0.3× 29 966
Ding Ren Shen United States 18 680 0.8× 272 1.2× 42 0.3× 87 0.8× 33 0.4× 35 1.1k
Yoshihito Ueno Japan 24 1.6k 1.9× 371 1.6× 28 0.2× 87 0.8× 22 0.2× 147 2.0k
Joseph Blecha United States 19 207 0.3× 53 0.2× 60 0.5× 163 1.5× 158 1.7× 54 979
A. K. Wong Australia 17 683 0.9× 210 0.9× 17 0.1× 101 0.9× 50 0.5× 21 1.3k
Haim Barr Israel 16 662 0.8× 147 0.6× 17 0.1× 133 1.2× 51 0.6× 35 953
Marek Cebrat Poland 17 637 0.8× 96 0.4× 44 0.3× 178 1.6× 98 1.1× 50 866

Countries citing papers authored by Shengxi Chen

Since Specialization
Citations

This map shows the geographic impact of Shengxi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengxi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengxi Chen more than expected).

Fields of papers citing papers by Shengxi Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengxi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengxi Chen. The network helps show where Shengxi Chen may publish in the future.

Co-authorship network of co-authors of Shengxi Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Shengxi Chen. A scholar is included among the top collaborators of Shengxi Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengxi Chen. Shengxi Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Shengxi, et al.. (2025). Alteration of CD40 Protein Expression by Tyrosine Phosphorylation of the NF‐ κ B p50 Subunit. ChemBioChem. 27(1). e202500710–e202500710.
2.
Chen, Shengxi, et al.. (2025). Using In Vitro Models to Study the Interactions Between Environmental Exposures and Human Microbiota. Microorganisms. 13(2). 247–247. 1 indexed citations
3.
4.
Ji, Xun, et al.. (2020). Double-component diazeniumdiolate derivatives as anti-cancer agents. Bioorganic & Medicinal Chemistry. 28(8). 115405–115405. 4 indexed citations
5.
Zhang, Fanghua, Xueli Yang, Jie Du, et al.. (2020). <p>Enhancing Antitumor Efficacy of Nucleoside Analog 5-Fluorodeoxyuridine on HER2-Overexpressing Breast Cancer by Affibody-Engineered DNA Nanoparticle</p>. International Journal of Nanomedicine. Volume 15. 885–900. 24 indexed citations
6.
Jiang, Haihe, et al.. (2015). Inhibition of microRNA-101 attenuates hypoxia/reoxygenation-induced apoptosis through induction of autophagy in H9c2 cardiomyocytes. Molecular Medicine Reports. 11(5). 3988–3994. 29 indexed citations
7.
Wang, Zhongjie, et al.. (2015). Fluorescent CD4 probe for potential HIV-1 gp120 protein detection. Bioorganic & Medicinal Chemistry Letters. 25(6). 1182–1185. 3 indexed citations
8.
Yu, Xiaobo, Chandrabali Bhattacharya, Nour Eddine Fahmi, et al.. (2014). Probing of CD4 binding pocket of HIV-1 gp120 glycoprotein using unnatural phenylalanine analogues. Bioorganic & Medicinal Chemistry Letters. 24(24). 5699–5703. 6 indexed citations
9.
Chen, Shengxi, et al.. (2014). Tryptophan-based fluorophores for studying protein conformational changes. Bioorganic & Medicinal Chemistry. 22(21). 5924–5934. 29 indexed citations
10.
Maini, Rumit, Dan T. Nguyen, Shengxi Chen, et al.. (2013). Incorporation of β-amino acids into dihydrofolate reductase by ribosomes having modifications in the peptidyltransferase center. Bioorganic & Medicinal Chemistry. 21(5). 1088–1096. 65 indexed citations
11.
Li, Yingqiu, et al.. (2013). Integrated Chinese-Western therapy versus Western therapy alone on survival rate of patients with middle-late stage non-small-cell lung cancer middle-late stage. Journal of Traditional Chinese Medicine. 33(4). 433–438. 10 indexed citations
12.
Yu, Zhiqiang, et al.. (2013). Design and expression of a short peptide as an HIV detection probe. Biochemical and Biophysical Research Communications. 443(1). 308–312. 24 indexed citations
13.
Zhou, Hui, et al.. (2012). [Correlation between podoplanin-positive lymphatic microvessel density and CT characteristics of non-small cell lung cancer].. SHILAP Revista de lepidopterología. 15(1). 34–8. 2 indexed citations
14.
Chen, Shengxi, et al.. (2012). Synthesis of pdCpAs and transfer RNAs activated with thiothreonine and derivatives. Bioorganic & Medicinal Chemistry. 20(8). 2679–2689. 9 indexed citations
15.
Li, Li, Wanjun Luo, Lingjin Huang, et al.. (2010). Remote Perconditioning Reduces Myocardial Injury in Adult Valve Replacement: A Randomized Controlled Trial. Journal of Surgical Research. 164(1). e21–e26. 86 indexed citations
16.
Duca, Maria, Shengxi Chen, & Sidney M. Hecht. (2008). Modeling the reactive properties of tandemly activated tRNAs. Organic & Biomolecular Chemistry. 6(18). 3292–3292. 8 indexed citations
17.
Chen, Shengxi, et al.. (2008). Chemical and Traditional Mutagenesis of Vaccinia DNA Topoisomerase Provides Insights to Cleavage Site Recognition and Transesterification Chemistry. Journal of Biological Chemistry. 283(23). 16093–16103. 16 indexed citations
18.
Huang, Lingjin, Shengxi Chen, Yan Huang, et al.. (2006). Proteomics-based identification of secreted protein dihydrodiol dehydrogenase as a novel serum markers of non-small cell lung cancer. Lung Cancer. 54(1). 87–94. 69 indexed citations
19.
Chen, Shengxi, et al.. (2001). 3-Keto-9-O-substituted Oxime Derivatives of 6-O-Methyl Erythromycin A Synthesis and In Vitro Activity.. The Journal of Antibiotics. 54(6). 506–509. 4 indexed citations
20.
Guo-hu, LI, et al.. (1998). Protective Effects of Ischemic Preconditioning on Donor Lung in Canine Lung Transplantation. CHEST Journal. 113(5). 1356–1359. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Devkumar Mustafi Breakdown of academic impact, for papers by L B Chen Breakdown of academic impact, for papers by J. Keith Wright Breakdown of academic impact, for papers by Gerda Szakonyi Breakdown of academic impact, for papers by Ding Ren Shen Breakdown of academic impact, for papers by Yoshihito Ueno Breakdown of academic impact, for papers by Joseph Blecha Breakdown of academic impact, for papers by A. K. Wong Breakdown of academic impact, for papers by Haim Barr Breakdown of academic impact, for papers by Marek Cebrat
Rankless by CCL
2026